MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL)
CUSIP: 558868105
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 22,766,960
- Total 13F shares
- 11,229,236
- Share change
- -981,208
- Total reported value
- $1,093,866,439
- Put/Call ratio
- 92%
- Price per share
- $97.41
- Number of holders
- 147
- Value change
- -$99,083,348
- Number of buys
- 87
- Number of sells
- 50
Quarterly Holders Quick Answers
What is CUSIP 558868105?
CUSIP 558868105 identifies MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 558868105:
Top shareholders of MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
|
Company |
8.3%
|
1,893,066
|
$221,432,000 | — | 31 Mar 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
6.6%
|
1,499,213
|
$175,363,000 | — | 31 Mar 2021 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
6.3%
|
1,425,000
|
$166,682,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.4%
|
997,809
|
$116,713,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.2%
|
956,096
|
$111,836,000 | — | 31 Mar 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.6%
|
816,834
|
$95,546,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
585,750
|
$68,515,000 | — | 31 Mar 2021 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1.5%
|
350,000
|
$40,940,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
262,894
|
$30,751,000 | — | 31 Mar 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.1%
|
258,500
|
$30,237,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.97%
|
219,805
|
$25,710,000 | — | 31 Mar 2021 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.94%
|
214,425
|
$25,081,000 | — | 31 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.79%
|
180,215
|
$21,080,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
0.78%
|
178,640
|
$20,896,000 | — | 31 Mar 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.76%
|
172,511
|
$20,178,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.68%
|
154,796
|
$18,106,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.55%
|
124,176
|
$14,525,000 | — | 31 Mar 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.51%
|
115,840
|
$13,550,000 | — | 31 Mar 2021 | |
| L1 Capital Pty Ltd |
13F
|
Company |
0.49%
|
112,604
|
$13,171,000 | — | 31 Mar 2021 | |
| NORGES BANK |
13F
|
Company |
0.47%
|
106,566
|
$12,465,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.44%
|
100,578
|
$11,765,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.39%
|
88,846
|
$10,392,000 | — | 31 Mar 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.38%
|
85,541
|
$10,006,000 | — | 31 Mar 2021 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.36%
|
82,534
|
$9,654,000 | — | 31 Mar 2021 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.32%
|
72,342
|
$8,462,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.28%
|
64,359
|
$7,529,000 | — | 31 Mar 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.27%
|
62,323
|
$7,290,000 | — | 31 Mar 2021 | |
| Tao Capital Management LP |
13F
|
Company |
0.23%
|
51,396
|
$6,012,000 | — | 31 Mar 2021 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.17%
|
39,721
|
$4,646,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.16%
|
35,293
|
$4,128,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
34,827
|
$4,074,000 | — | 31 Mar 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.15%
|
34,282
|
$4,010,000 | — | 31 Mar 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.15%
|
33,951
|
$3,971,000 | — | 31 Mar 2021 | |
| Capital Impact Advisors, LLC |
13F
|
Company |
0.15%
|
33,048
|
$3,866,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.14%
|
31,641
|
$3,701,000 | — | 31 Mar 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.13%
|
30,454
|
$3,562,000 | — | 31 Mar 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
0.14%
|
31,722
|
$3,387,000 | — | 31 Mar 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.13%
|
28,751
|
$3,363,000 | — | 31 Mar 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.12%
|
28,275
|
$3,307,000 | — | 31 Mar 2021 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.12%
|
27,979
|
$3,273,000 | — | 31 Mar 2021 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.12%
|
26,522
|
$3,102,000 | — | 31 Mar 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.1%
|
23,654
|
$2,768,000 | — | 31 Mar 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.1%
|
23,294
|
$2,725,000 | — | 31 Mar 2021 | |
| Swiss National Bank |
13F
|
Company |
0.1%
|
23,000
|
$2,690,000 | — | 31 Mar 2021 | |
| NATIXIS |
13F
|
Company |
0.1%
|
22,000
|
$2,573,000 | — | 31 Mar 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.09%
|
19,464
|
$2,277,000 | — | 31 Mar 2021 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.08%
|
19,277
|
$2,255,000 | — | 31 Mar 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
19,168
|
$2,242,000 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.08%
|
17,900
|
$2,094,000 | — | 31 Mar 2021 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.07%
|
17,060
|
$1,996,000 | — | 31 Mar 2021 |
Institutional Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q2 2021
As of 30 Jun 2021,
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) was held by
147 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,229,236 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, ARMISTICE CAPITAL, LLC, Capital Research Global Investors, Rock Springs Capital Management LP, and Artisan Partners Limited Partnership.
This page lists
147
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
135
Q2 2021 holders
147
Holder diff
12
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.